Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...
Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...
Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...
Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...
Besides navigating with Gemini, Google Maps is rolling out other AI-powered features, like landmark-based navigation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results